SCHEMBL4288322

SCHEMBL4288322

CC1CC(=O)C2=C1CCCC2

nearest known ligand 0.38

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
▸ CA1 P00915 1/20 0.38
▸ CA2 P00918 1/20 0.38
▸ CA4 P22748 1/20 0.38
▸ KMT2A Q03164 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11572154 0.98 KMT2A (0.40) CA1CA2CA4KMT2A
SCHEMBL8419229 0.98 KMT2A (0.40) CA1CA2CA4KMT2A
SCHEMBL21940584 0.95 CA1 (0.33) CA1CA2CA4KMT2A
SCHEMBL22388204 0.74 TLR4 (0.33) CA1CA2CA4KMT2A
SCHEMBL22388203 0.74 TLR4 (0.33) CA1CA2CA4KMT2A
SCHEMBL19141681 0.74 CA1 (0.35) CA1CA2CA4KMT2A
SCHEMBL20464012 0.71 — —
SCHEMBL4290685 0.71 — —
SCHEMBL21812504 0.66 POLB (0.39) KMT2A
SCHEMBL4288359 0.66 CA1 (0.32) CA1CA2CA4KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 77 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3856709-B1 SYNTHESIS OF CYCLOPENTENONES DOW GLOBAL TECHNOLOGIES LLC (US) 2024-06-26 — — EP claimed
CN-112601731-B Synthesis of cyclopentenone 陶氏环球技术有限责任公司 2023-10-03 — — CN claimed
US-11292757-B2 Synthesis of cyclopentenones DOW GLOBAL TECHNOLOGIES LLC (US) 2022-04-05 — — US claimed
EP-3856709-A1 SYNTHESIS OF CYCLOPENTENONES Dow Global Technologies LLC (US) 2021-08-04 — — EP claimed
US-20210206709-A1 SYNTHESIS OF CYCLOPENTENONES DOW GLOBAL TECHNOLOGIES LLC 2021-07-08 — — US claimed
WO-2020068419-A1 SYNTHESIS OF CYCLOPENTENONES DOW GLOBAL TECHNOLOGIES LLC (US) 2020-04-02 — — WO claimed
EP-3856752-B1 SYNTHESIS OF SUBSTITUTED CYCLOPENTADIENE COMPOUNDS AND METALLOCENES DOW GLOBAL TECHNOLOGIES LLC (US) 2026-04-29 — — EP disclosed
EP-3688003-B1 SYNTHESIS OF CYCLIC ORGANIC COMPOUNDS AND METALLOCENES UNIVATION TECH LLC (US) 2024-10-16 — — EP disclosed
CN-112638923-B Synthesis of substituted cyclopentadiene compounds and metallocenes 陶氏环球技术有限责任公司 2024-10-15 — — CN disclosed
EP-3812390-B1 SYNTHESIS OF CYCLIC ORGANIC COMPOUNDS AND METALLOCENES UNIVATION TECH LLC (US) 2024-07-03 — — EP disclosed
EP-3856709-B1 SYNTHESIS OF CYCLOPENTENONES DOW GLOBAL TECHNOLOGIES LLC (US) 2024-06-26 — — EP disclosed
EP-3856709-B1 SYNTHESIS OF CYCLOPENTENONES DOW GLOBAL TECHNOLOGIES LLC (US) 2024-06-26 — — EP disclosed
CN-117886682-A Synthesis of cyclic organic compounds and metallocenes 尤尼威蒂恩技术有限责任公司 2024-04-16 — — CN disclosed
EP-0705269-B1 TITANIUM(II) OR ZIRCONIUM(II) COMPLEXES AND ADDITION POLYMERIZATION CATALYSTS THEREFROM DOW CHEMICAL CO (US) 1997-01-15 — — EP disclosed
US-5556928-A COORDINATION CATALYSTS FOR ADDITION POLYMERIZATION THE DOW CHEMICAL COMPANY (US) 1996-09-17 — — US disclosed
EP-0705269-A1 TITANIUM(II) OR ZIRCONIUM(II) COMPLEXES AND ADDITION POLYMERIZATION CATALYSTS THEREFROM DOW CHEMICAL CO (US) 1996-04-10 — — EP disclosed
EP-0520732-B1 Homogeneous olefin polymerization catalyst by ligand abstraction with lewis acids DOW CHEMICAL CO (US) 1995-12-06 — — EP disclosed
US-5470993-A Titanium(II) or zirconium(II) complexes and addition polymerization catalysts therefrom THE DOW CHEMICAL COMPANY (US) 1995-11-28 — — US disclosed
WO-1995000526-A1 TITANIUM(II) OR ZIRCONIUM(II) COMPLEXES AND ADDITION POLYMERIZATION CATALYSTS THEREFROM THE DOW CHEMICAL COMPANY (US) 1995-01-05 — — WO disclosed
EP-0520732-A1 Homogeneous olefin polymerization catalyst by ligand abstraction with lewis acids THE DOW CHEMICAL COMPANY (US) 1992-12-30 — — EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210206709-A1 SYNTHESIS OF CYCLOPENTENONES FDPS, COASY, DHPS CA1 2944/4885CA2 2741/4885CA4 1811/4885
US-11292757-B2 Synthesis of cyclopentenones FDPS, COASY, DHPS CA1 2944/4885CA2 2741/4885CA4 1811/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback